Header cover image

Japanese (NIKKEI) Drug Retail Industry Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies19
  • 7D11.9%
  • 3M17.3%
  • 1Y5.9%
  • YTDn/a

In the last week, the Drug Retail industry is up 7.2%, with Tsuruha Holdings leading the way with a 21% gain. In the last 12 months, the industry was up 3.9%. Earnings are forecast to grow by 9.6% annually.

Industry Valuation and Performance

Has the Japanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025JP¥4.5tJP¥8.3tJP¥210.1b17.5x21.3x0.5x
Thu, 13 Mar 2025JP¥4.0tJP¥8.3tJP¥218.6b16.9x18.2x0.5x
Sat, 08 Feb 2025JP¥3.9tJP¥8.2tJP¥216.5b17x17.8x0.5x
Mon, 06 Jan 2025JP¥3.8tJP¥8.1tJP¥217.7b16.3x17.5x0.5x
Wed, 04 Dec 2024JP¥3.8tJP¥8.1tJP¥219.3b16.2x17.2x0.5x
Fri, 01 Nov 2024JP¥3.7tJP¥8.0tJP¥222.2b16.2x16.8x0.5x
Sun, 29 Sep 2024JP¥4.1tJP¥8.0tJP¥222.8b17.6x18.3x0.5x
Tue, 27 Aug 2024JP¥3.9tJP¥7.9tJP¥220.6b16.5x17.8x0.5x
Thu, 25 Jul 2024JP¥3.9tJP¥7.9tJP¥221.4b16.5x17.5x0.5x
Sat, 22 Jun 2024JP¥3.8tJP¥7.8tJP¥227.2b16.4x16.9x0.5x
Mon, 20 May 2024JP¥4.1tJP¥7.8tJP¥226.0b17x18.1x0.5x
Wed, 17 Apr 2024JP¥4.3tJP¥7.7tJP¥226.3b16.7x18.8x0.5x
Fri, 15 Mar 2024JP¥4.4tJP¥7.6tJP¥223.3b15x19.5x0.6x
Sun, 11 Feb 2024JP¥4.4tJP¥7.6tJP¥219.1b14.5x20x0.6x
Tue, 09 Jan 2024JP¥4.4tJP¥7.5tJP¥218.4b14.8x20.1x0.6x
Thu, 07 Dec 2023JP¥4.4tJP¥7.5tJP¥215.5b16x20.4x0.6x
Sat, 04 Nov 2023JP¥4.2tJP¥7.4tJP¥211.7b15.6x20x0.6x
Mon, 02 Oct 2023JP¥4.2tJP¥7.3tJP¥210.9b16.6x20x0.6x
Wed, 30 Aug 2023JP¥4.8tJP¥7.7tJP¥221.6b18.6x21.6x0.6x
Fri, 28 Jul 2023JP¥4.7tJP¥7.8tJP¥221.5b18.8x21.2x0.6x
Sun, 25 Jun 2023JP¥4.7tJP¥7.7tJP¥222.5b17.5x20.9x0.6x
Tue, 23 May 2023JP¥4.6tJP¥7.7tJP¥219.9b17.4x21x0.6x
Thu, 20 Apr 2023JP¥4.2tJP¥7.6tJP¥219.3b16x19.2x0.6x
Sat, 18 Mar 2023JP¥4.0tJP¥7.5tJP¥218.0b16.2x18.5x0.5x
Mon, 13 Feb 2023JP¥4.1tJP¥7.5tJP¥221.7b17x18.5x0.5x
Wed, 11 Jan 2023JP¥4.3tJP¥7.4tJP¥219.1b18x19.7x0.6x
Fri, 09 Dec 2022JP¥4.3tJP¥7.4tJP¥215.4b16.8x19.8x0.6x
Sun, 06 Nov 2022JP¥4.0tJP¥7.3tJP¥209.8b16.3x19.2x0.6x
Tue, 04 Oct 2022JP¥4.1tJP¥7.2tJP¥207.2b15.1x19.6x0.6x
Thu, 01 Sep 2022JP¥4.1tJP¥7.1tJP¥207.4b15.8x19.6x0.6x
Sat, 30 Jul 2022JP¥3.9tJP¥7.1tJP¥205.9b14.8x19x0.6x
Mon, 27 Jun 2022JP¥3.7tJP¥7.0tJP¥203.4b14.1x18.4x0.5x
Wed, 25 May 2022JP¥3.4tJP¥7.0tJP¥205.9b13.1x16.7x0.5x
Fri, 22 Apr 2022JP¥3.5tJP¥6.9tJP¥202.7b14.6x17.4x0.5x
Price to Earnings Ratio

17.4x


Total Market Cap: JP¥3.5tTotal Earnings: JP¥202.7bTotal Revenue: JP¥6.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Drug Retail Industry Price to Earnings3Y Average 19x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Drug Retail industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 20.9x which is higher than its 3-year average PE of 19.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.54x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Japanese Drug Retail compare with similar industries?

JP Market8.73%
Consumer Staples7.63%
Food and Staples Retail8.99%
Drug Retail11.87%
Food Retail8.50%
Food Distributors8.44%
Big Box Super Stores7.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3391 Tsuruha HoldingsJP¥11.28k15.2%
+JP¥72.3b
10.6%PE26.6x
3141 Welcia HoldingsJP¥2.48k13.7%
+JP¥62.4b
8.5%PE34.4x
3349 COSMOS PharmaceuticalJP¥8.44k9.8%
+JP¥59.8b
21.0%PE22.7x
7649 Sugi HoldingsLtdJP¥3.02k6.3%
+JP¥58.2b
26.7%PE21.3x
3088 MatsukiyoCocokaraJP¥2.52k5.4%
+JP¥52.1b
5.7%PE19.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.